Document Detail

Marine n-3 Fatty Acids for Cardiovascular Risk Reduction and Disease Control in Rheumatoid Arthritis: "Kill Two Birds with One Stone"?
MedLine Citation:
PMID:  22364137     Owner:  NLM     Status:  Publisher    
Rheumatoid arthritis (RA), the most common chronic systemic inflammatory disease leading to joint destruction and disability, is associated with increased cardiovascular mortality. Systemic inflammation and increased burden of traditional cardiovascular risk factors present in RA are currently considered responsible for the accelerated atherosclerosis in these patients. Herein, we highlight a potential double effect of dietary intake of the n-3 long-chain polyunsaturated fatty acids (LCP) eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) on cardiovascular risk reduction and disease control in patients with RA. Large studies in non-RA populations provide strong evidence for the beneficial effect of n-3 LCP supplementation in primary and secondary cardiovascular prevention. Cardiovascular risk reduction is at least partly explained by n-3 LCP effects on blood pressure, dyslipidemia, thrombosis and inflammation, all important factors also in RA, whereas abnormalities in vascular function and in vascular morphology similar to those observed in RA patients may even be moderately reversed. On the other hand, there is evidence from 6 of 14 randomized controlled trials supporting a favorable effect of n-3 LCP supplementation in decreasing joint inflammation in RA. Although specific studies in RA patients are currently lacking, a double beneficial effect of n-3 LCP seems likely. The size of any such effect and how it compares with other interventions such as lifestyle changes, biologic therapies, and statin therapy, needs to be investigated prospectively in carefully designed studies.
Victoria G Rontoyanni; Petros P Sfikakis; George D Kitas; Athanase D Protogerou
Related Documents :
9681977 - 15n investigation into the effect of a pollutant on the nitrogen metabolism of tetrahym...
16829407 - Nitrogen utilization during postoperative, low nitrogen, high caloric parenteral nutrit...
2918517 - Studies on prodrugs. 10. possible mechanism of n-dealkylation of n-masked norfloxacins ...
11732677 - Additivity and associative effects of metabolizable energy and amino acid digestibility...
20805577 - Fatty acid modulation and polyamine block of gluk2 kainate receptors analyzed by scanni...
12599457 - The first catalytic asymmetric addition of dialkylzincs to alpha-ketoesters.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-24
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, "Laikon" Hospital, Ag. Thoma, 17, 11527 Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the rece...
Next Document:  Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Resear...